ParkinsonFranceV1, PascalFrancis, Curation, bibRecord, 000070

Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts

Identifieur interne : 000070 ( PascalFrancis/Curation ); précédent : 000069; suivant : 000071

Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts

Auteurs : M. C. De Rijk [Pays-Bas] ; L. J. Launer [Pays-Bas, États-Unis] ; K. Berger [Allemagne] ; M. M. B. Breteler [Pays-Bas] ; J.-F. Dartigues [France] ; M. Baldereschi [Italie] ; L. Fratiglioni [Suède] ; A. Lobo [Espagne] ; J. Martinez-Lage [Espagne] ; C. Trenkwalder [Allemagne] ; A. Hofman [Pays-Bas]

Source :

Neurology [ 0028-3878 ] ; 2000.

RBID : Pascal:00-0326443

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Europe, Etude cohorte, Prévalence, Epidémiologie, Etude comparative, Personne âgée.
Wicri :
- topic : Personne âgée.

English descriptors

KwdEn :
- Cohort study, Comparative study, Elderly, Epidemiology, Europe, Parkinson disease, Prevalence.

Abstract

Article abstract-The results of seven population-based studies were examined separately and pooled to obtain age- and sex-specific estimates of the prevalence of PD. An in-person screening instrument and diagnostic clinical examination were used to detect potential PD cases. The overall prevalence (per 100 population) in persons 65 years of age and older was 1.8, with an increase from 0.6 for those age 65 to 69 years to 2.6 for those 85 to 89 years. There were no sex differences in prevalence of PD.

A01	`01`	`1`		`@0 0028-3878`
A02	`01`			`@0 NEURAI`
A03		`1`		`@0 Neurology`
A05				`@2 54`
A06				`@2 11 @3 SUP5`
A08	`01`	`1`	`ENG`	`@1 Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts`
A09	`01`	`1`	`ENG`	`@1 Frequency and Impact of Neurologic Diseases in the Elderly of Europe`
A11	`01`	`1`		`@1 DE RIJK (M. C.)`
A11	`02`	`1`		`@1 LAUNER (L. J.)`
A11	`03`	`1`		`@1 BERGER (K.)`
A11	`04`	`1`		`@1 BRETELER (M. M. B.)`
A11	`05`	`1`		`@1 DARTIGUES (J.-F.)`
A11	`06`	`1`		`@1 BALDERESCHI (M.)`
A11	`07`	`1`		`@1 FRATIGLIONI (L.)`
A11	`08`	`1`		`@1 LOBO (A.)`
A11	`09`	`1`		`@1 MARTINEZ-LAGE (J.)`
A11	`10`	`1`		`@1 TRENKWALDER (C.)`
A11	`11`	`1`		`@1 HOFMAN (A.)`
A12	`01`	`1`		`@1 LAUNER (Lenore J.) @9 ed.`
A12	`02`	`1`		`@1 HOFMAN (Albert) @9 ed.`
A14	`01`			`@1 Department of Epidemiology & Biostatistics, Erasmus Medical Center @2 Rotterdam @3 NLD @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 11 aut.`
A14	`02`			`@1 Epidemiology, Demography, Biometry Program, National Institute on Aging @2 Bethesda, MD @3 USA @Z 2 aut.`
A14	`03`			`@1 Institute of Epidemiolgy and Social Medicine, University of Muenster @3 DEU @Z 3 aut.`
A14	`04`			`@1 INSERM U330 @2 Bordeaux @3 FRA @Z 5 aut.`
A14	`05`			`@1 National Research Council (CNR-CSFET), Italian Longitudinal Study on Aging @2 Florence @3 ITA @Z 6 aut.`
A14	`06`			`@1 Division Geriatric Medicine, NEUROTEC, Karolinska Institutet, Stockholm Gerontology Research Center @3 SWE @Z 7 aut.`
A14	`07`			`@1 Department of Psychiatry, Zaragoza University @3 ESP @Z 8 aut.`
A14	`08`			`@1 Department of Neurology, University of Navarra @3 ESP @Z 9 aut.`
A14	`09`			`@1 Max-Planck Institute of Psychiatry @2 Munich @3 DEU @Z 10 aut.`
A15	`01`			`@1 Department of Epidemiology & Biostatistics, Erasmus Medical Center @2 Rotterdam @3 NLD @Z 1 aut. @Z 2 aut.`
A15	`02`			`@1 Epidemiology, Demography, Biometry Program, National Institute on Aging @2 Bethesda, Maryland @3 USA @Z 1 aut.`
A17	`01`	`1`		`@1 Neurologic Diseases in the Elderly Research Group @3 INC`
A20				`@2 S21-S23`
A21				`@1 2000`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 6345 @5 354000088769070050`
A44				`@0 0000 @1 © 2000 INIST-CNRS. All rights reserved.`
A45				`@0 13 ref.`
A47	`01`	`1`		`@0 00-0326443`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Neurology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Article abstract-The results of seven population-based studies were examined separately and pooled to obtain age- and sex-specific estimates of the prevalence of PD. An in-person screening instrument and diagnostic clinical examination were used to detect potential PD cases. The overall prevalence (per 100 population) in persons 65 years of age and older was 1.8, with an increase from 0.6 for those age 65 to 69 years to 2.6 for those 85 to 89 years. There were no sex differences in prevalence of PD.
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Europe @2 NG @5 04`
C03	`02`	`X`	`ENG`	`@0 Europe @2 NG @5 04`
C03	`02`	`X`	`SPA`	`@0 Europa @2 NG @5 04`
C03	`03`	`X`	`FRE`	`@0 Etude cohorte @5 07`
C03	`03`	`X`	`ENG`	`@0 Cohort study @5 07`
C03	`03`	`X`	`SPA`	`@0 Estudio cohorte @5 07`
C03	`04`	`X`	`FRE`	`@0 Prévalence @5 17`
C03	`04`	`X`	`ENG`	`@0 Prevalence @5 17`
C03	`04`	`X`	`SPA`	`@0 Prevalencia @5 17`
C03	`05`	`X`	`FRE`	`@0 Epidémiologie @5 18`
C03	`05`	`X`	`ENG`	`@0 Epidemiology @5 18`
C03	`05`	`X`	`SPA`	`@0 Epidemiología @5 18`
C03	`06`	`X`	`FRE`	`@0 Etude comparative @5 19`
C03	`06`	`X`	`ENG`	`@0 Comparative study @5 19`
C03	`06`	`X`	`SPA`	`@0 Estudio comparativo @5 19`
C03	`07`	`X`	`FRE`	`@0 Personne âgée @5 20`
C03	`07`	`X`	`ENG`	`@0 Elderly @5 20`
C03	`07`	`X`	`SPA`	`@0 Anciano @5 20`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`03`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`03`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`03`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`04`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`04`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`04`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`05`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`05`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`05`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`06`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`06`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`06`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`07`	`X`	`FRE`	`@0 Santé publique @5 45`
C07	`07`	`X`	`ENG`	`@0 Public health @5 45`
C07	`07`	`X`	`SPA`	`@0 Salud pública @5 45`
N21				`@1 220`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001368

Links to Exploration step

Pascal:00-0326443

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts</title>
<author><name sortKey="De Rijk, M C" sort="De Rijk, M C" uniqKey="De Rijk M" first="M. C." last="De Rijk">M. C. De Rijk</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Launer, L J" sort="Launer, L J" uniqKey="Launer L" first="L. J." last="Launer">L. J. Launer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology, Demography, Biometry Program, National Institute on Aging</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Berger, K" sort="Berger, K" uniqKey="Berger K" first="K." last="Berger">K. Berger</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Institute of Epidemiolgy and Social Medicine, University of Muenster</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Breteler, M M B" sort="Breteler, M M B" uniqKey="Breteler M" first="M. M. B." last="Breteler">M. M. B. Breteler</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Dartigues, J F" sort="Dartigues, J F" uniqKey="Dartigues J" first="J.-F." last="Dartigues">J.-F. Dartigues</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>INSERM U330</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Baldereschi, M" sort="Baldereschi, M" uniqKey="Baldereschi M" first="M." last="Baldereschi">M. Baldereschi</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>National Research Council (CNR-CSFET), Italian Longitudinal Study on Aging</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Fratiglioni, L" sort="Fratiglioni, L" uniqKey="Fratiglioni L" first="L." last="Fratiglioni">L. Fratiglioni</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Division Geriatric Medicine, NEUROTEC, Karolinska Institutet, Stockholm Gerontology Research Center</s1>
<s3>SWE</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Lobo, A" sort="Lobo, A" uniqKey="Lobo A" first="A." last="Lobo">A. Lobo</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Psychiatry, Zaragoza University</s1>
<s3>ESP</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Martinez Lage, J" sort="Martinez Lage, J" uniqKey="Martinez Lage J" first="J." last="Martinez-Lage">J. Martinez-Lage</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Neurology, University of Navarra</s1>
<s3>ESP</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C." last="Trenkwalder">C. Trenkwalder</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Max-Planck Institute of Psychiatry</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Hofman, A" sort="Hofman, A" uniqKey="Hofman A" first="A." last="Hofman">A. Hofman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0326443</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0326443 INIST</idno>
<idno type="RBID">Pascal:00-0326443</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001368</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000070</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts</title>
<author><name sortKey="De Rijk, M C" sort="De Rijk, M C" uniqKey="De Rijk M" first="M. C." last="De Rijk">M. C. De Rijk</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Launer, L J" sort="Launer, L J" uniqKey="Launer L" first="L. J." last="Launer">L. J. Launer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology, Demography, Biometry Program, National Institute on Aging</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Berger, K" sort="Berger, K" uniqKey="Berger K" first="K." last="Berger">K. Berger</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Institute of Epidemiolgy and Social Medicine, University of Muenster</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Breteler, M M B" sort="Breteler, M M B" uniqKey="Breteler M" first="M. M. B." last="Breteler">M. M. B. Breteler</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Dartigues, J F" sort="Dartigues, J F" uniqKey="Dartigues J" first="J.-F." last="Dartigues">J.-F. Dartigues</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>INSERM U330</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Baldereschi, M" sort="Baldereschi, M" uniqKey="Baldereschi M" first="M." last="Baldereschi">M. Baldereschi</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>National Research Council (CNR-CSFET), Italian Longitudinal Study on Aging</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Fratiglioni, L" sort="Fratiglioni, L" uniqKey="Fratiglioni L" first="L." last="Fratiglioni">L. Fratiglioni</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Division Geriatric Medicine, NEUROTEC, Karolinska Institutet, Stockholm Gerontology Research Center</s1>
<s3>SWE</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Lobo, A" sort="Lobo, A" uniqKey="Lobo A" first="A." last="Lobo">A. Lobo</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Psychiatry, Zaragoza University</s1>
<s3>ESP</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Martinez Lage, J" sort="Martinez Lage, J" uniqKey="Martinez Lage J" first="J." last="Martinez-Lage">J. Martinez-Lage</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Neurology, University of Navarra</s1>
<s3>ESP</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C." last="Trenkwalder">C. Trenkwalder</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Max-Planck Institute of Psychiatry</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Hofman, A" sort="Hofman, A" uniqKey="Hofman A" first="A." last="Hofman">A. Hofman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurology</title>
<idno type="ISSN">0028-3878</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurology</title>
<idno type="ISSN">0028-3878</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cohort study</term>
<term>Comparative study</term>
<term>Elderly</term>
<term>Epidemiology</term>
<term>Europe</term>
<term>Parkinson disease</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Europe</term>
<term>Etude cohorte</term>
<term>Prévalence</term>
<term>Epidémiologie</term>
<term>Etude comparative</term>
<term>Personne âgée</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Personne âgée</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Article abstract-The results of seven population-based studies were examined separately and pooled to obtain age- and sex-specific estimates of the prevalence of PD. An in-person screening instrument and diagnostic clinical examination were used to detect potential PD cases. The overall prevalence (per 100 population) in persons 65 years of age and older was 1.8, with an increase from 0.6 for those age 65 to 69 years to 2.6 for those 85 to 89 years. There were no sex differences in prevalence of PD.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0028-3878</s0>
</fA01>
<fA02 i1="01"><s0>NEURAI</s0>
</fA02>
<fA03 i2="1"><s0>Neurology</s0>
</fA03>
<fA05><s2>54</s2>
</fA05>
<fA06><s2>11</s2>
<s3>SUP5</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Frequency and Impact of Neurologic Diseases in the Elderly of Europe</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>DE RIJK (M. C.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LAUNER (L. J.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BERGER (K.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>BRETELER (M. M. B.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>DARTIGUES (J.-F.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>BALDERESCHI (M.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>FRATIGLIONI (L.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>LOBO (A.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>MARTINEZ-LAGE (J.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>TRENKWALDER (C.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>HOFMAN (A.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>LAUNER (Lenore J.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>HOFMAN (Albert)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Epidemiology, Demography, Biometry Program, National Institute on Aging</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Institute of Epidemiolgy and Social Medicine, University of Muenster</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>INSERM U330</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>National Research Council (CNR-CSFET), Italian Longitudinal Study on Aging</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Division Geriatric Medicine, NEUROTEC, Karolinska Institutet, Stockholm Gerontology Research Center</s1>
<s3>SWE</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Psychiatry, Zaragoza University</s1>
<s3>ESP</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Department of Neurology, University of Navarra</s1>
<s3>ESP</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Max-Planck Institute of Psychiatry</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Epidemiology, Demography, Biometry Program, National Institute on Aging</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA17 i1="01" i2="1"><s1>Neurologic Diseases in the Elderly Research Group</s1>
<s3>INC</s3>
</fA17>
<fA20><s2>S21-S23</s2>
</fA20>
<fA21><s1>2000</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>6345</s2>
<s5>354000088769070050</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>13 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>00-0326443</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Article abstract-The results of seven population-based studies were examined separately and pooled to obtain age- and sex-specific estimates of the prevalence of PD. An in-person screening instrument and diagnostic clinical examination were used to detect potential PD cases. The overall prevalence (per 100 population) in persons 65 years of age and older was 1.8, with an increase from 0.6 for those age 65 to 69 years to 2.6 for those 85 to 89 years. There were no sex differences in prevalence of PD.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Europe</s0>
<s2>NG</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Europe</s0>
<s2>NG</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Europa</s0>
<s2>NG</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Etude cohorte</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Cohort study</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Estudio cohorte</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Prévalence</s0>
<s5>17</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Prevalence</s0>
<s5>17</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Prevalencia</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>18</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>18</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Etude comparative</s0>
<s5>19</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Comparative study</s0>
<s5>19</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Estudio comparativo</s0>
<s5>19</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Personne âgée</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Elderly</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Anciano</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Public health</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>45</s5>
</fC07>
<fN21><s1>220</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000070 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000070 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:00-0326443
   |texte=   Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts

Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri